1st Aug 2022 19:38
Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Existing shareholder AOP Health International Management agrees to loan USD10 million to Shield, which will draw it down in a single tranche, and being secured over Shield's US intellectual property rights. Read More